Nox4 Antibodies

Santa Cruz Biotechnology features a diverse variety of Nox4 monoclonal antibodies for advanced research in oxidative stress and cellular signaling. Nox4 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Nox4, or NADPH oxidase 4, plays a critical role in the production of reactive oxygen species (ROS) and is involved in various physiological and pathological processes, including inflammation, fibrosis, and cancer. Nox4 regulation is essential for maintaining cellular homeostasis, and understanding Nox4 dysregulation can provide insights into disease mechanisms. Research focusing on Nox4 is particularly significant in cardiovascular and neurodegenerative diseases, where oxidative stress is a key factor. Scientists worldwide rely on Nox4 monoclonal antibodies to advance their understanding of oxidative stress pathways and cellular responses. Investigating Nox4 expression and activity patterns helps reveal new therapeutic targets for various diseases. Santa Cruz Biotechnology monoclonal antibodies support researchers in making meaningful contributions to the scientific understanding of oxidative stress and its impact on human health.